Thursday, November 29, 2018 12:17:30 PM
Mymetics Corp. (otcqb: MYMX)
Imminent Catalysts:
1) Collaboration with Sanofi Pasteur(vaccine unit of giant pharma Sanofi) will conclude this year's (2018) end. Successful outcome will lead to either exclusive licensing deal of Mymetics' proprietary VLP platform for use in Sanofi's influenza vaccines or buyout.
2) Collaboration with Anergis,SA which preclinical results expected at year's (2018) end or 1st Q of 2019. A successful outcome will lead to exclusive worldwide licensing deal with Mymetics' proprietary VLP platform for use in all of Anergis' allergy immunotherapy vaccines.
3) MACIVIVA(Manufacturing for cold chain independent virosome based vaccines) of which Mymetics is leading a consortium of 4 other companies including giant CMO Catalent(NYSE:CTLT) using Mymetics' HIV-1 vaccine will conclude this month of November 2018.
4) A possibility of advancing Mymetics' HIV-1 vaccine to Phase Ib - II under the framework of MACIVIVA project.
GLTA
Recent CTLT News
- Perficient Stock Soars 52.9% Post-Acquisition; Luminar Declines 10% Amid Workforce Cutbacks, and Other News • IH Market News • 05/06/2024 12:09:00 PM
- Tesla Resolves Autopilot Lawsuit, JPMorgan Unveils Potential CEO Successors, and More • IH Market News • 04/09/2024 10:39:30 AM
- CNOOC Oil Field Discovery in South China Sea, Grifols Surges 18% After KPMG Approval, and Latest News • IH Market News • 03/08/2024 11:19:59 AM
- Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment • Business Wire • 03/07/2024 01:00:00 PM
- Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm • PR Newswire (US) • 02/27/2024 03:50:00 PM
- Cisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest News • IH Market News • 02/15/2024 11:34:25 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 07:23:55 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:04:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/12/2024 10:09:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 01:04:59 PM
- Catalent, Inc. Reports Second Quarter Fiscal 2024 Results • Business Wire • 02/09/2024 12:59:00 PM
- Cloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14% After CEO Resignation, and More • IH Market News • 02/09/2024 10:51:57 AM
- Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More • IH Market News • 02/06/2024 11:14:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/05/2024 10:22:51 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/05/2024 12:03:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 12:00:31 PM
- Novo Holdings to Acquire Catalent • Business Wire • 02/05/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:09:05 PM
- Catalent, Inc. Announces Second Quarter Fiscal Year 2024 Earnings Conference Webcast • Business Wire • 01/26/2024 06:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 02:00:32 PM
- Catalent Commits to Reducing Greenhouse Gas Emissions by 2030 • Business Wire • 01/25/2024 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 01:51:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 02:01:55 PM
- Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/04/2024 01:44:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM